An official American Thoracic Society/American College of Chest Physicians policy statement: Implementation of low-dose computed tomography lung cancer screening programs in clinical practice

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 7, 2015, Pages 881-891

  Wiener, Renda Soylemez ^b   Gould, Michael K ^b   Arenberg, Douglas A ^b   Au, David H ^b   Fennig, Kathleen ^b   Lamb, Carla R ^b   Mazzone, Peter J ^b   Midthun, David E ^b   Napoli, Maryann ^a   Ost, David E ^b   Powell, Charles A ^b   Rivera, M Patricia ^b   Slatore, Christopher G ^b   Tanner, Nichole T ^b   Vachani, Anil ^b   Wisnivesky, Juan P ^b   Yoon, Sue H ^b   Black, William C ^b   Detterbeck, Frank ^b   Hirschowitz, Edward ^b   Jett, James ^b   Kinsinger, Linda ^b   more..

^a Center for Medical Consumers   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LOW ENERGY RADIATION; LUNG CANCER; LUNG NODULE; MEDICARE; MIDDLE AGED; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RADIATION EXPOSURE; SMOKING; SMOKING CESSATION; VERY ELDERLY; DIAGNOSTIC IMAGING; ECONOMICS; LUNG TUMOR; MASS SCREENING; MEDICAL SOCIETY; RADIATION DOSE; STANDARDS; THORAX RADIOGRAPHY; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

HUMANS; LUNG NEOPLASMS; MASS SCREENING; RADIATION DOSAGE; RADIOGRAPHY, THORACIC; SMOKING CESSATION; SOCIETIES, MEDICAL; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84943262834     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201508-1671ST     Document Type: Article

References (84)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest 2013;143:e78S-e92S.
3. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): lung cancer screening, version 1.2015. 2014 [accessed 2014 Dec 14]. Available from: http://www.nccn.org/professionals/physician-gls/pdf/lung-screening.pdf
5. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-38.
6. American Lung Association Lung Cancer Screening Committee. Providing guidance on lung cancer screening to patients and physicans. 2012 [accessed 2015 Apr 13]. Available from: http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf
7. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, et al.; IASLC CT Screening Workshop 2011 Participants. International association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10-19.
8. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.
9. Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE, Golin CE, DeFrank JT, Brewer NT. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014;174:281-285.
10. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med 2013;159:411-420.
11. Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest 2015;147:295-303.
12. Centers for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG- 00439N). 2015 [accessed 2015 Feb 21]. Available from: http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx? NCAId=274&NcaName=Screening1for1Lung1Cancer1with1Low 1Dose1Computed1Tomography1(LDCT)&MEDCACId=68&IsPopup= y&bc=AAAAAAAAAgAAAA%3d%3d&
13. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999;89:1322-1327.
14. Rycroft-Malone J, Kitson A, Harvey G, McCormack B, Seers K, Titchen A, Estabrooks C. Ingredients for change: revisiting a conceptual framework. Qual Saf Health Care 2002;11:174-180.
15. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
16. Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening: systematic review in support of the U.S. Preventive Services Task Force. Ann Am Thorac Soc 2014;11:619-627.
17. Slatore CG, Sullivan DR, Pappas M, Humphrey LL. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol 2014;9:927-934.
18. American Academy of Family Physicians. Clinical Preventive Service recommendation: lung cancer. 2013 [accessed 2014 Sept 24]. Available from: http://www.aafp.org/patient-care/clinicalrecommendations/all/lung-cancer.html
19. McKee A, McKee B, Wald C, Lamb C, Hesketh PJ, Flacke S. Rescue lung, rescue life: translating the NLST results into clinical practice. Oncology Issues 2014;Mar-Apr:20-29.
20. McKee BJ, McKee AB, Flacke S, Lamb CR, Hesketh PJ, Wald C. Initial experience with a free, high-volume, low-dose CT lung cancer screening program. J Am Coll Radiol 2013;10:586-592.
21. Mazzone P. The rationale for, and design of, a lung cancer screening program. Cleve Clin J Med 2012;79:337-345.
22. Arenberg D, Kazerooni EA. Setting up a lung cancer screening program. J Natl Compr Canc Netw 2012;10:277-285.
23. Bach P. CT scam: don't believe the hype about lung-cancer screenings. 2010 [accessed 2014 Dec 8]. Available from: http://www.slate.com/articles/health-and-science/medical-examiner/2010/11/ct-scam.html
24. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-254.
25. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012;157:571-573.
26. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976-3983.
27. Federman DG, Kravetz JD, Lerz KA, Akgun KM, Ruser C, Cain H, Anderson EF, Taylor C. Implementation of an electronic clinical reminder to improve rates of lung cancer screening. Am J Med 2014;127:813-816.
28. Wiener RS, Ouellette DR, Diamond E, Fan VS, Maurer JR, Mularski RA, Peters JI, Halpern SD; American Thoracic Society; American College of Chest Physicians. An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. Chest 2014;145:1383-1391.
29. Consumer Reports. CT scans to find lung cancer: when you need them-and when you don't. 2014 [accessed 2014 Dec 1]. Available from:http://www.choosingwisely.org/doctor-patient-lists/ct-scansto-find-lung-cancer-in-smokers/
30. Wiener RS, Koppelman E, Slatore CG, Clark JA. Patients' impressions of communication with their clinicians surrounding low-dose CT lung cancer screening: a qualitative study [abstract]. Am J Respir Crit Care Med 2015;191:A6120.
31. Stacey D, Kryworuchko J, Bennett C, Murray MA, Mullan S, Légaré F. Decision coaching to prepare patients for making health decisions: a systematic review of decision coaching in trials of patient decision AIDS. Med Decis Making 2012;32:E22-E33.
32. Presidential Commission for the Study of Bioethical Issues. Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. 2013 [accessed 2014 Dec 1]. Available from: http://bioethics.gov/node/3183
33. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:94S-107S.
34. National Cancer Institute. Patient and physician guide: National Lung Screening Trial (NLST) [accessed 2015 Apr 13]. Available from: http://www.cancer.gov/newscenter/qa/2002/NLSTstudyGuidePatientsPhysicians
35. Bach PB, Elkin EB, Pastorino U, Kattan MW, Mushlin AI, Begg CB, Parkin DM. Benchmarking lung cancer mortality rates in current and former smokers. Chest 2004;126:1742-1749.
36. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-478.
37. Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst 2006;98:637-640.
38. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-726.
39. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-736.
40. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-276.
41. McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M, Screaton N, Rintoul RC, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362-371.
42. Volk RJ, Linder SK, Leal VB, Rabius V, Cinciripini PM, Kamath GR, Munden RF, Bevers TB. Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prev Med 2014;62:60-63.
43. Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg D, Meza R. Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol. JMIR Res Protoc 2014;3:e78.
44. Lillie SE, Partin MR, Rice K, Fabbrini AE, Greer NL, Patel S, MacDonald R, Rutks I, Wilt TJ. The effects of shared decision making on cancer screening: a systematic review. 2014. VA ESP Project No. #09-009.
45. Kazerooni EA, Austin JH, Black WC, Dyer DS, Hazelton TR, Leung AN, McNitt-Gray MF, Munden RF, Pipavath S; American College of Radiology; Society of Thoracic Radiology. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging 2014;29:310-316.
46. Gierada DS, Pilgram TK, Ford M, Fagerstrom RM, Church TR, Nath H, Garg K, Strollo DC. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology 2008;246:265-272.
47. Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J. National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology 2013;268:865-873.
48. Singh S, Pinsky P, Fineberg NS, Gierada DS, Garg K, Sun Y, Nath PH. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology 2011;259:263-270.
49. Wiener RS, Gould MK, Slatore CG, Fincke BG, Schwartz LM, Woloshin S. Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med 2014;174:871-880.
50. American College of Radiology. Lung CT screening reporting and data system (Lung-RADS) [accessed 2015 Apr 13]. Available from: http://www.acr.org/Quality-Safety/Resources/LungRADS
51. Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E. Performance of Lung-RADS in the national lung screening trial: a retrospective assessment. Ann Intern Med 2015;162:485-491.
52. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2015;12:273-276.
53. Woloshin S, Schwartz LM, Dann E, Black WC. Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules: a preliminary study. Ann Am Thorac Soc 2014;11:211-214.
54. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF Jr, Swensen SJ; Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.
55. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S-120S.
56. Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, ten Haaf K, Nackaerts K, Lammers JW, Weenink C, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-1341.
57. Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-1350.
58. Kinsinger LS, Atkins D, Provenzale D, Anderson C, Petzel R. Implementation of a new screening recommendation in health care: the Veterans Health Administration's approach to lung cancer screening. Ann Intern Med 2014;161:597-598.
59. Alsamarai S, Yao X, Cain HC, Chang BW, Chao HH, Connery DM, Deng Y, Garla VN, Hunnibell LS, Kim AW, et al. The effect of a lung cancer care coordination program on timeliness of care. Clin Lung Cancer 2013;14:527-534.
60. Goulart BH, Ramsey SD. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist 2013;18:941-946.
61. McClure MA, Rice KL, Lindsey B. Novel automated lung nodule tracking system: 5 year preliminary results [abstract]. Am J Respir Crit Care Med 2013;187:A2349.
62. Moseson EM, Slatore CG, Golden SE. Adherence to Fleischner Society guidelines among veterans with pulmonary nodules in a clinical registry [abstract]. Am J Respir Crit Care Med 2014;189:A2251.
63. Hunnibell LS, Slatore CG, Ballard EA. Foundations for lung nodule management for nurse navigators. Clin J Oncol Nurs 2013;17: 525-531.
64. Slatore CG, Golden SE, Ganzini L, Wiener RS, Au DH. Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules: a cohort study. Ann Am Thorac Soc 2015;12:184-192.
65. Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. What do you mean, a spot?: a qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest 2013;143:672-677.
66. Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 2012;172:837-844.
67. van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer 2012;76:204-210.
68. Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Vickers K, Hurt RD, Swensen SJ. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer 2004;44:13-21.
69. Folan P, Massucci D; Tobacco Control Committee of the American Thoracic Society. American Thoracic Society series on tobacco: resources to help you stop using tobacco [accessed 2015 Apr 13]. Available from: http://www.thoracic.org/patients/patient-resources/resources/resources-stop-using-tobacco.pdf
70. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013;8:CD002850.
71. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network metaanalysis. Cochrane Database Syst Rev 2013;5:CD009329.
72. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;5:CD000165.
73. Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2012;12:CD009670.
74. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699-709.
75. Whittaker R, McRobbie H, Bullen C, Borland R, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2012;11:CD006611.
76. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med 2008;35:158-176.
77. Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e61S-e77S.
78. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, Logan PM. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006;61:54-56.
79. Ferketich AK, Otterson GA, King M, Hall N, Browning KK, Wewers ME. A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 2012;76:211-215.
80. Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 2014;106:dju084.
81. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007;56:125-134.
82. Smoking Cessation Leadership Center. Tobacco cessation education: a training program for faculty [accessed 2015 Apr 13]. Available from: http://smokingcessationleadership.ucsf.edu/webinars/tobaccocessation-education
83. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336:598-600.
84. Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg DA, Meza R. Improving lung cancer screening decision-making through a personalized, web-based decision aid. Am J Prev Med (In press)